CA Patent

CA2438595C — Glucopyranosyloxypyrazole derivatives and medicinal use thereof

Assigned to Kissei Pharmaceutical Co Ltd · Expires 2011-08-09 · 15y expired

What this patent protects

The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: (see above formula) wherein R1, R2 and R3 represent a hydrogen atom or a halogen atom; R4 represents a lower alkyl group or a halo (lower alkyl) group; and R5 represents a…

USPTO Abstract

The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: (see above formula) wherein R1, R2 and R3 represent a hydrogen atom or a halogen atom; R4 represents a lower alkyl group or a halo (lower alkyl) group; and R5 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, etc., a pharmaceutically acceptable salt thereof or a prodrug thereof., which exert an excellent inhibitory activity in human SGLT2, and therefore are useful as drugs for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, pharmaceutically acceptable salts thereof or prodrugs thereof, production intermediates thereof and pharmaceutical uses thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA2438595C
Jurisdiction
CA
Classification
Expires
2011-08-09
Drug substance claim
No
Drug product claim
No
Assignee
Kissei Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.